180 related articles for article (PubMed ID: 14598513)
21. A randomized trial of adding fluoxetine to a naltrexone treatment programme for heroin addicts.
Landabaso MA; Iraurgi I; Jiménez-Lerma JM; Sanz J; Fernádez de Corres B; Araluce K; Calle R; Gutiérrez-Fraile M
Addiction; 1998 May; 93(5):739-44. PubMed ID: 9692272
[TBL] [Abstract][Full Text] [Related]
22. A new approach to preventing relapse in opiate addicts: a psychometric evaluation.
Grüsser SM; Thalemann CN; Platz W; Gölz J; Partecke G
Biol Psychol; 2006 Mar; 71(3):231-5. PubMed ID: 16046046
[TBL] [Abstract][Full Text] [Related]
23. [Depression].
Mischo M; Nigg C; Kiss A
Praxis (Bern 1994); 2010 Mar; 99(5):271-6; quiz 277-8. PubMed ID: 20205083
[No Abstract] [Full Text] [Related]
24. Naltrexone and buprenorphine combination in the treatment of opioid dependence.
Gerra G; Fantoma A; Zaimovic A
J Psychopharmacol; 2006 Nov; 20(6):806-14. PubMed ID: 16401652
[TBL] [Abstract][Full Text] [Related]
25. A double-blind, double-dummy, randomized controlled study of memantine versus buprenorphine in naloxone-precipitated acute withdrawal in heroin addicts.
Jain K; Jain R; Dhawan A
J Opioid Manag; 2011; 7(1):11-20. PubMed ID: 21434580
[TBL] [Abstract][Full Text] [Related]
26. A non-selective (amitriptyline), but not a selective (citalopram), serotonin reuptake inhibitor is effective in the prophylactic treatment of chronic tension-type headache.
Bendtsen L; Jensen R; Olesen J
J Neurol Neurosurg Psychiatry; 1996 Sep; 61(3):285-90. PubMed ID: 8795600
[TBL] [Abstract][Full Text] [Related]
27. Heroin detoxification.
Favrat B; Besson J
JAMA; 2006 Feb; 295(8):885; author reply 886. PubMed ID: 16493096
[No Abstract] [Full Text] [Related]
28. Heroin detoxification.
Miller MM
JAMA; 2006 Feb; 295(8):885-6; author reply 886. PubMed ID: 16493095
[No Abstract] [Full Text] [Related]
29. Hostility in heroin abusers subtypes: fluoxetine and naltrexone treatment.
Gerra G; Fertonani G; Zaimovic A; Rota-Graziosi I; Avanzini P; Caccavari R; Delsignore R; Lucchini A
Prog Neuropsychopharmacol Biol Psychiatry; 1995 Dec; 19(8):1225-37. PubMed ID: 8868205
[TBL] [Abstract][Full Text] [Related]
30. [A new quality of the therapy of anxiety and depression--escitalopram].
Neznanov NG; Bortsov AV
Zh Nevrol Psikhiatr Im S S Korsakova; 2005; 105(2):79-84. PubMed ID: 15792148
[No Abstract] [Full Text] [Related]
31. Clinical evaluation of naltrexone treatment of opiate-dependent individuals. Report of the National Research Council Committee on Clinical Evaluation of Narcotic Antagonists.
Arch Gen Psychiatry; 1978 Mar; 35(3):335-40. PubMed ID: 365122
[TBL] [Abstract][Full Text] [Related]
32. Naltrexone shortened opioid detoxification with buprenorphine.
Umbricht A; Montoya ID; Hoover DR; Demuth KL; Chiang CT; Preston KL
Drug Alcohol Depend; 1999 Oct; 56(3):181-90. PubMed ID: 10529020
[TBL] [Abstract][Full Text] [Related]
33. Heroin anticraving medications: a systematic review.
Fareed A; Vayalapalli S; Casarella J; Amar R; Drexler K
Am J Drug Alcohol Abuse; 2010 Nov; 36(6):332-41. PubMed ID: 20955107
[TBL] [Abstract][Full Text] [Related]
34. An evaluation of antidepressants in rheumatic pain conditions.
Rani PU; Naidu MU; Prasad VB; Rao TR; Shobha JC
Anesth Analg; 1996 Aug; 83(2):371-5. PubMed ID: 8694321
[TBL] [Abstract][Full Text] [Related]
35. Overcoming opioid blockade from depot naltrexone (Prodetoxon).
Kruptisky EM; Burakov AM; Tsoy MV; Egorova VY; Slavina TY; Grinenko AY; Zvartau EE; Woody GE
Addiction; 2007 Jul; 102(7):1164-5. PubMed ID: 17498182
[TBL] [Abstract][Full Text] [Related]
36. Safety, efficacy, and long-term results of a modified version of rapid opiate detoxification under general anaesthesia: a prospective study in methadone, heroin, codeine and morphine addicts.
Hensel M; Kox WJ
Acta Anaesthesiol Scand; 2000 Mar; 44(3):326-33. PubMed ID: 10714849
[TBL] [Abstract][Full Text] [Related]
37. A comparison of antagonist-precipitated withdrawal under anesthesia to standard inpatient withdrawal as a precursor to maintenance naltrexone treatment in heroin users: outcomes at 6 and 12 months.
McGregor C; Ali R; White JM; Thomas P; Gowing L
Drug Alcohol Depend; 2002 Sep; 68(1):5-14. PubMed ID: 12167548
[TBL] [Abstract][Full Text] [Related]
38. Anesthesia-assisted vs buprenorphine- or clonidine-assisted heroin detoxification and naltrexone induction: a randomized trial.
Collins ED; Kleber HD; Whittington RA; Heitler NE
JAMA; 2005 Aug; 294(8):903-13. PubMed ID: 16118380
[TBL] [Abstract][Full Text] [Related]
39. Remission with mirtazapine and selective serotonin reuptake inhibitors: a meta-analysis of individual patient data from 15 controlled trials of acute phase treatment of major depression.
Thase ME; Nierenberg AA; Vrijland P; van Oers HJ; Schutte AJ; Simmons JH
Int Clin Psychopharmacol; 2010 Jul; 25(4):189-98. PubMed ID: 20531012
[TBL] [Abstract][Full Text] [Related]
40. Acute antidepressive efficacy of lithium monotherapy, not citalopram, depends on recurrent course of depression.
Bschor T; Uhr M; Baethge C; Lewitzka U; Ising M; Erbe S; Winkelmann P; Ritter D
J Clin Psychopharmacol; 2013 Feb; 33(1):38-44. PubMed ID: 23277245
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
